Mesenchymal stem cells alleviate idiopathic pneumonia syndrome by modulating T cell function through CCR2-CCL2 axis

BACKGROUND: Idiopathic pneumonia syndrome (IPS) is a non-infectious fatal complication characterized by a massive infiltration of leukocytes in lungs and diffuse pulmonary injury after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Conventional immunosuppressive treatments for IPS h...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Min, Liu, Huihui, Dong, Yujun, Liu, Wei, Yu, Zhengyu, Wang, Qingya, Wang, Qingyun, Liang, Zeying, Li, Yuan, Ren, Hanyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254317/
https://www.ncbi.nlm.nih.gov/pubmed/34215321
http://dx.doi.org/10.1186/s13287-021-02459-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254317/
https://www.ncbi.nlm.nih.gov/pubmed/34215321
http://dx.doi.org/10.1186/s13287-021-02459-7

Ejemplares similares